Phase I / II, multicenter, randomized and controlled clinical trial to assess the safety and efficacy of intravenous administration of expanded Allogeneic Adipose Tissue Adult Mesenchymal Stem cells in patients with severe pneumonia due to COVID-19
- Funded by Centro Regulador de Urgencias y Emergencias (CRUE Santander)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AKnown Financial Commitments (USD)
$169,500Funder
Centro Regulador de Urgencias y Emergencias (CRUE Santander)Research Location
SpainLead Research Institution
Universidad de SevillaResearch Priority Alignment
N/A
Research Category
Clinical characterisation and managementResearch Subcategory
Supportive care, processes of care and managementSpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
Clinical Trial, Phase IBroad Policy Alignment
PendingAge Group
Adults (18 and older)Vulnerable Population
UnspecifiedOccupations of Interest
Unspecified